Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON20352Not yet recruiting
Randomised, open-label trial of influenza vaccine in influenza (3 arms), sponsored by University Medical Center of Southern Nevada. Primary endpoint: Adequate rise in antibody titre. Planned start Sep 2011; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON20352.